Story perspectives

AI in nAMD Treatment: Promising but Needs Regulation

9/21/2025

46 6

Summary

Story summary

A retrospective study on AI-enabled treatment monitoring for nAMD shows a need for interventional research to evaluate clinical impacts.
The study suggests AI could enhance NHS efficiency by reducing overtreatment.
Current AI systems require qualified healthcare professionals for decision-making due to lack of regulatory approval for autonomous use.
Similar opportunities for treatment accuracy improvement were identified across two NHS centers.
Regulatory recertification for AI systems may take around 18 months.

1 of 1

Story summary

A retrospective study on AI-enabled treatment monitoring for nAMD shows a need for interventional research to evaluate clinical impacts.
The study suggests AI could enhance NHS efficiency by reducing overtreatment.
Current AI systems require qualified healthcare professionals for decision-making due to lack of regulatory approval for autonomous use.
Similar opportunities for treatment accuracy improvement were identified across two NHS centers.
Regulatory recertification for AI systems may take around 18 months.